Monday, January 12, 2009

Acclarent Gets $26M

Menlo Park-based Acclarent, which develops medical devices for treating ear, nose, and throat conditions, said today that it has raised $26M in a financing round. The round came from Johnson & Johnson Development Corporation, along with existing investors New Enterprise Associates, Delphi Ventures, Versant Ventures, and Meritech Capital Partners. the firm said the funding will go towards commercialization of its technology, as well as for product development and clinical studies. More information »